Day: June 3, 2023

PR Newswire

Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST

June 3, 2023
edd1994

ROCKVILLE, Md. and SUZHOU, China, June 3, 2023 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent") (HKEX: 01801),…

PR Newswire

ATFX Receives Exclusive Invitation to Join Africa Summit

June 3, 2023
edd1994

KUALA LUMPUR, Malaysia, June 3, 2023 /PRNewswire/ — ATFX participated in the 2023 Africa Summit, organized…